Ameliorating Alzheimer's-like pathology by Minocycline via inhibiting Cdk5/p25 signaling

CONCLUSION: Minocycline mitigates Alzheimer's-like pathology via limiting the activation of Cdk5/p25 signaling pathway and improves cognitive deficits.PMID:34856907 | DOI:10.2174/1570159X19666211202124925

Source: Current Neuropharmacology - December 3, 2021 Category: Drugs & Pharmacology Authors: Yu Zhao Chuanling Wang Wenbo He Zhiyou Cai Source Type: research